285 related articles for article (PubMed ID: 30091171)
1. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
[TBL] [Abstract][Full Text] [Related]
2. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
[TBL] [Abstract][Full Text] [Related]
3. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
4. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
5. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
[TBL] [Abstract][Full Text] [Related]
6. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
[TBL] [Abstract][Full Text] [Related]
7. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
Friberg L; Hammar N; Rosenqvist M
Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
[TBL] [Abstract][Full Text] [Related]
8. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
[TBL] [Abstract][Full Text] [Related]
9. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
10. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
[TBL] [Abstract][Full Text] [Related]
11. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
12. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
[TBL] [Abstract][Full Text] [Related]
13. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
[TBL] [Abstract][Full Text] [Related]
14. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.
Qureshi W; O'Neal WT; Soliman EZ; Al-Mallah MH
Cardiol J; 2016; 23(3):333-43. PubMed ID: 27064796
[TBL] [Abstract][Full Text] [Related]
16. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
[TBL] [Abstract][Full Text] [Related]
17. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
[TBL] [Abstract][Full Text] [Related]
18. Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Van den Berg MP; Van Gelder IC;
Heart Rhythm; 2014 Sep; 11(9):1543-50. PubMed ID: 24924587
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Rate-Control Treatment in Patients With Atrial Fibrillation and Heart Failure - A Nationwide Cohort Study.
Yu HT; Yang PS; Lee H; You SC; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B
Circ J; 2018 Feb; 82(3):652-658. PubMed ID: 29142156
[TBL] [Abstract][Full Text] [Related]
20. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
